vs
CSW INDUSTRIALS, INC.（CSW）とNATURES SUNSHINE PRODUCTS INC（NATR）の財務データ比較。上の社名をクリックして会社を切り替えられます
CSW INDUSTRIALS, INC.の直近四半期売上が大きい（$233.0M vs $123.8M、NATURES SUNSHINE PRODUCTS INCの約1.9倍）。CSW INDUSTRIALS, INC.の純利益率が高く（4.4% vs 3.3%、差は1.1%）。CSW INDUSTRIALS, INC.の前年同期比売上増加率が高い（20.3% vs 4.7%）。CSW INDUSTRIALS, INC.の直近四半期フリーキャッシュフローが多い（$22.7M vs $7.6M）。過去8四半期でNATURES SUNSHINE PRODUCTS INCの売上複合成長率が高い（5.6% vs 5.1%）
Natures Sunshine Products, Inc.（通称NSP）は、ハーブ、ビタミン、ミネラルを含む栄養補助食品やスキンケアなどのパーソナルケア製品の製造を行っています。本社はユタ州リーハイに置き、同州スパニッシュフォークに生産拠点を構えています。
CSW vs NATR — 直接比較
売上が大きい
CSW
1.9倍大きい
$123.8M
売上成長率が高い
CSW
+15.6%の差
4.7%
純利益率が高い
CSW
純利益率が1.1%高い
3.3%
フリーキャッシュフローが多い
CSW
FCF $15.2M多い
$7.6M
2年売上CAGRが高い
NATR
2年複合成長率
5.1%
損益計算書 — Q3 FY2026 vs Q4 FY2025
| 指標 | | |
|---|---|---|
| 売上 | $233.0M | $123.8M |
| 純利益 | $10.3M | $4.1M |
| 粗利率 | 39.7% | 72.5% |
| 営業利益率 | 7.4% | 4.3% |
| 純利益率 | 4.4% | 3.3% |
| 売上前年比 | 20.3% | 4.7% |
| 純利益前年比 | -61.9% | 1379.4% |
| EPS（希薄化後） | $0.62 | $0.23 |
緑 = その指標でリード。会計年度がずれている場合は期間が異なる場合あり
8四半期 売上・利益トレンド
並べて比較する四半期履歴。決算期がずれていても暦四半期で整列
売上CSWNATR
| Q4 25 | $233.0M | $123.8M | ||
| Q3 25 | $277.0M | $128.3M | ||
| Q2 25 | $263.6M | $114.8M | ||
| Q1 25 | $230.5M | $113.2M | ||
| Q4 24 | $193.6M | $118.2M | ||
| Q3 24 | $227.9M | $114.6M | ||
| Q2 24 | $226.2M | $110.6M | ||
| Q1 24 | $210.9M | $111.0M |
純利益CSWNATR
| Q4 25 | $10.3M | $4.1M | ||
| Q3 25 | $40.7M | $5.3M | ||
| Q2 25 | $40.9M | $5.3M | ||
| Q1 25 | $35.1M | $4.7M | ||
| Q4 24 | $26.9M | $-321.0K | ||
| Q3 24 | $36.1M | $4.3M | ||
| Q2 24 | $38.6M | $1.3M | ||
| Q1 24 | $31.8M | $2.3M |
粗利率CSWNATR
| Q4 25 | 39.7% | 72.5% | ||
| Q3 25 | 43.0% | 73.3% | ||
| Q2 25 | 43.8% | 71.7% | ||
| Q1 25 | 44.2% | 72.1% | ||
| Q4 24 | 41.4% | 72.0% | ||
| Q3 24 | 45.6% | 71.3% | ||
| Q2 24 | 47.5% | 71.4% | ||
| Q1 24 | 44.4% | 71.2% |
営業利益率CSWNATR
| Q4 25 | 7.4% | 4.3% | ||
| Q3 25 | 20.5% | 7.0% | ||
| Q2 25 | 20.8% | 3.7% | ||
| Q1 25 | 19.5% | 5.4% | ||
| Q4 24 | 15.3% | 3.8% | ||
| Q3 24 | 22.6% | 4.6% | ||
| Q2 24 | 24.3% | 5.1% | ||
| Q1 24 | 21.0% | 4.2% |
純利益率CSWNATR
| Q4 25 | 4.4% | 3.3% | ||
| Q3 25 | 14.7% | 4.2% | ||
| Q2 25 | 15.5% | 4.6% | ||
| Q1 25 | 15.2% | 4.2% | ||
| Q4 24 | 13.9% | -0.3% | ||
| Q3 24 | 15.8% | 3.8% | ||
| Q2 24 | 17.1% | 1.2% | ||
| Q1 24 | 15.1% | 2.1% |
EPS（希薄化後）CSWNATR
| Q4 25 | $0.62 | $0.23 | ||
| Q3 25 | $2.41 | $0.30 | ||
| Q2 25 | $2.43 | $0.28 | ||
| Q1 25 | $2.05 | $0.25 | ||
| Q4 24 | $1.60 | $-0.02 | ||
| Q3 24 | $2.26 | $0.23 | ||
| Q2 24 | $2.47 | $0.07 | ||
| Q1 24 | $2.03 | $0.12 |
貸借対照表と財務力
直近四半期の流動性・レバレッジ・純資産のスナップショット
| 指標 | | |
|---|---|---|
| 現金・短期投資手元流動性 | $40.2M | $93.9M |
| 総負債低いほど良い | — | — |
| 株主資本純資産 | $1.1B | $161.6M |
| 総資産 | $2.3B | $261.1M |
| 負債/資本比率低いほどレバレッジが低い | — | — |
8四半期トレンド — 暦四半期で整列
現金・短期投資CSWNATR
| Q4 25 | $40.2M | $93.9M | ||
| Q3 25 | $31.5M | $95.6M | ||
| Q2 25 | $38.0M | $81.3M | ||
| Q1 25 | $225.8M | $86.5M | ||
| Q4 24 | $213.8M | $84.7M | ||
| Q3 24 | $273.2M | $78.7M | ||
| Q2 24 | $18.9M | $68.7M | ||
| Q1 24 | $22.2M | $77.8M |
総負債CSWNATR
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | $800.1M | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | $166.0M | $2.1M |
株主資本CSWNATR
| Q4 25 | $1.1B | $161.6M | ||
| Q3 25 | $1.1B | $166.7M | ||
| Q2 25 | $1.1B | $163.7M | ||
| Q1 25 | $1.1B | $167.1M | ||
| Q4 24 | $1.0B | $161.0M | ||
| Q3 24 | $1.0B | $162.6M | ||
| Q2 24 | $650.2M | $156.4M | ||
| Q1 24 | $615.7M | $159.7M |
総資産CSWNATR
| Q4 25 | $2.3B | $261.1M | ||
| Q3 25 | $1.5B | $264.8M | ||
| Q2 25 | $1.5B | $254.9M | ||
| Q1 25 | $1.4B | $252.7M | ||
| Q4 24 | $1.4B | $240.9M | ||
| Q3 24 | $1.4B | $245.3M | ||
| Q2 24 | $1.1B | $235.8M | ||
| Q1 24 | $1.0B | $247.3M |
負債/資本比率CSWNATR
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | 0.75× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 0.27× | 0.01× |
キャッシュフローと資本効率
再投資後に実際に生み出すキャッシュ。純利益より操作が難しい
| 指標 | | |
|---|---|---|
| 営業キャッシュフロー直近四半期 | $28.9M | $9.9M |
| フリーキャッシュフロー営業CF - 設備投資 | $22.7M | $7.6M |
| FCFマージンFCF / 売上 | 9.8% | 6.1% |
| 設備投資強度設備投資 / 売上 | 2.6% | 1.9% |
| キャッシュ転換率営業CF / 純利益 | 2.81× | 2.41× |
| 直近12ヶ月FCF直近4四半期 | $162.0M | $28.8M |
8四半期トレンド — 暦四半期で整列
営業キャッシュフローCSWNATR
| Q4 25 | $28.9M | $9.9M | ||
| Q3 25 | $61.8M | $18.5M | ||
| Q2 25 | $60.6M | $4.3M | ||
| Q1 25 | $27.3M | $2.6M | ||
| Q4 24 | $11.6M | $12.2M | ||
| Q3 24 | $66.8M | $9.6M | ||
| Q2 24 | $62.7M | $1.3M | ||
| Q1 24 | $22.4M | $2.2M |
フリーキャッシュフローCSWNATR
| Q4 25 | $22.7M | $7.6M | ||
| Q3 25 | $58.7M | $16.8M | ||
| Q2 25 | $57.7M | $3.0M | ||
| Q1 25 | $22.8M | $1.5M | ||
| Q4 24 | $8.5M | $10.0M | ||
| Q3 24 | $61.3M | $7.9M | ||
| Q2 24 | $59.6M | $-2.0M | ||
| Q1 24 | $17.5M | $-1.5M |
FCFマージンCSWNATR
| Q4 25 | 9.8% | 6.1% | ||
| Q3 25 | 21.2% | 13.1% | ||
| Q2 25 | 21.9% | 2.6% | ||
| Q1 25 | 9.9% | 1.3% | ||
| Q4 24 | 4.4% | 8.5% | ||
| Q3 24 | 26.9% | 6.9% | ||
| Q2 24 | 26.3% | -1.9% | ||
| Q1 24 | 8.3% | -1.4% |
設備投資強度CSWNATR
| Q4 25 | 2.6% | 1.9% | ||
| Q3 25 | 1.1% | 1.3% | ||
| Q2 25 | 1.1% | 1.2% | ||
| Q1 25 | 2.0% | 1.0% | ||
| Q4 24 | 1.6% | 1.9% | ||
| Q3 24 | 2.4% | 1.5% | ||
| Q2 24 | 1.4% | 3.0% | ||
| Q1 24 | 2.3% | 3.3% |
キャッシュ転換率CSWNATR
| Q4 25 | 2.81× | 2.41× | ||
| Q3 25 | 1.52× | 3.46× | ||
| Q2 25 | 1.48× | 0.81× | ||
| Q1 25 | 0.78× | 0.55× | ||
| Q4 24 | 0.43× | — | ||
| Q3 24 | 1.85× | 2.21× | ||
| Q2 24 | 1.62× | 0.97× | ||
| Q1 24 | 0.71× | 0.94× |
財務フロー比較
売上 → 粗利 → 営業利益 → 純利益のサンキー図
セグメント別売上内訳
CSW
| Contractor Solutions Segment | $166.3M | 71% |
| Specialized Reliability Solutions Segment | $38.2M | 16% |
| Engineered Building Solutions Segment | $28.5M | 12% |
NATR
| Other | $68.1M | 55% |
| General Health Products | $20.2M | 16% |
| Digestive Products | $13.8M | 11% |
| Cardiovascular Products | $12.1M | 10% |
| Personal Care Products | $4.4M | 4% |
| Immunity Products | $3.1M | 3% |
| Weight Management Products | $2.1M | 2% |
